CymaBay Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/6/2024

Shares

853,475

Value ($000)

20,159

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/6/2024	20,159	0.0%	853,475	12/31/2023
2023 Q3	11/8/2023	11,906	0.0%	798,555	9/30/2023
2023 Q2	8/10/2023	2,899	0.0%	264,734	6/30/2023
2023 Q1	5/12/2023	336	0.0%	38,480	3/31/2023
2022 Q4	2/13/2023	217	0.0%	34,566	12/31/2022
2022 Q3	11/14/2022	121	0.0%	34,566	9/30/2022
2022 Q2	8/15/2022	144	0.0%	48,612	6/30/2022
2022 Q1	5/13/2022	744	0.0%	239,215	3/31/2022
2021 Q4	2/11/2022	609	0.0%	179,959	12/31/2021
2021 Q3	11/16/2021	635	0.0%	173,959	9/30/2021
2021 Q2	8/16/2021	2,317	0.0%	531,334	6/30/2021
2021 Q1	5/17/2021	2,448	0.0%	539,114	3/31/2021
2020 Q4	2/16/2021	2,984	0.0%	519,693	12/31/2020
2020 Q3	11/13/2020	3,768	0.0%	520,418	9/30/2020
2020 Q2	8/20/2020	1,522	0.0%	435,930	6/30/2020
2020 Q1	5/15/2020	556	0.0%	375,265	3/31/2020
2019 Q4	2/7/2020	725	0.0%	369,704	12/31/2019